These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

672 related items for PubMed ID: 35272568

  • 1. Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study.
    Zhao Y, Cai M, Jiang Z, Dong B, Yan Y, Wang Y, Zuo L.
    Ren Fail; 2022 Dec; 44(1):428-433. PubMed ID: 35272568
    [Abstract] [Full Text] [Related]

  • 2. Effect of Glomerular Mannose-Binding Lectin Deposition on the Prognosis of Idiopathic Membranous Nephropathy.
    Zhang Y, Liu Y, Liang L, Liu L, Tang X, Tang L, Chen P, Chen J, Wang Z, Cao W, Chen Q, Zhao N, Xu D.
    Kidney Blood Press Res; 2020 Dec; 45(5):713-726. PubMed ID: 32894840
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Circulating antibodies against M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in Chinese patients with membranous nephropathy.
    Tian C, Li L, Liu T, Qu X, Qiu Y.
    Int Urol Nephrol; 2019 Aug; 51(8):1371-1377. PubMed ID: 31227982
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody as A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy.
    Zhang Q, Huang B, Liu X, Liu B, Zhang Y, Zhang Z, Hua J, Fan Y, Hu L, Meng M, Wu M, Wang L, Hu Z, Sun Z.
    Sci Rep; 2017 Sep 21; 7(1):12049. PubMed ID: 28935926
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. PLA2R and membranous nephropathy: A 3 year prospective Australian study.
    Hill PA, McRae JL, Dwyer KM.
    Nephrology (Carlton); 2016 May 21; 21(5):397-403. PubMed ID: 26369693
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.
    Hoxha E, Kneißler U, Stege G, Zahner G, Thiele I, Panzer U, Harendza S, Helmchen UM, Stahl RA.
    Kidney Int; 2012 Oct 21; 82(7):797-804. PubMed ID: 22673885
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy.
    Stefan G, Stancu S, Zugravu A, Popa O, Zubidat D, Petre N, Mircescu G.
    Ren Fail; 2022 Dec 21; 44(1):258-268. PubMed ID: 35172682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.